Mousa, Shaaban A <br/><br/>
Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain.  [electronic resource] 

 -  Brain : a journal of neurology  Feb 2007 
 - 502-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2156 
<br/><br/><label>Standard No.: </label>10.1093/brain/awl330  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analgesics, Opioid--therapeutic use<br/>Animals<br/>Apoptosis Regulatory Proteins--metabolism<br/>Calcitonin Gene-Related Peptide--metabolism<br/>Enzyme-Linked Immunosorbent Assay--methods<br/>Fentanyl--therapeutic use<br/>Ganglia, Spinal--metabolism<br/>Inflammation--chemically induced<br/>Male<br/>Nerve Growth Factor--physiology<br/>Neurons, Afferent--metabolism<br/>Pain--drug therapy<br/>Pain Threshold--drug effects<br/>Rats<br/>Rats, Wistar<br/>Receptor, trkA--metabolism<br/>Receptors, Opioid, mu--drug effects<br/>Sciatic Nerve--metabolism<br/>Skin--innervation<br/>Up-Regulation--drug effects